SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Mobile Health

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2146278

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2146278

Patient Experience Technology Market by Offerings, Functions (Appointment {Online Booking}, Registration {Intake}, Virtual Care {Telehealth, RPM}, Communication, Feedback), End User (Providers, Payers, Pharma & Biotech), Region - Global Forecast to 2031

PUBLISHED:
PAGES: 347 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The patient experience technology market is projected to grow from USD 0.74 billion in 2026 to USD 1.29 billion by 2031, at a CAGR of 11.8% during the forecast period. The market is entering a new phase of digital transformation as healthcare providers increasingly adopt technology across the patient journey rather than relying on standalone engagement tools.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsOfferings, Functions, End Users
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Growing adoption of AI-powered communication, digital patient portals, virtual care, online appointment scheduling, automated registration, and feedback management is enabling healthcare organizations to improve accessibility, personalization, and patient engagement. Increasing integration of patient experience platforms with EHRs, CRM systems, telehealth platforms, and analytics solutions is further creating opportunities for technology providers. As healthcare organizations place greater emphasis on patient-centric care, convenience, and experience-driven outcomes, demand for scalable and intelligent patient experience solutions is expected to increase substantially over the forecast period.

Patient Experience Technology Market - IMG1

"The cloud-based segment is projected to register high growth among software/platform segments during the forecast period."

Based on the offerings, the patient experience technology market is segmented into software/platform and services. The software/platform is divided into on-premise, cloud-based, and hybrid. The cloud-based platform is expected to see significant market growth during the forecast period due to its scalability, lower upfront costs, and ability to rapidly deploy updates. Healthcare providers increasingly favor cloud solutions for digital check-ins, telehealth triage, patient portals, and AI-driven personalization. Vendors such as Press Ganey, Qualtrics, and Epic are embedding cloud-native analytics, conversational AI, and ambient listening tools that improve flexibility and care access. For instance, in February 2025, Press Ganey partnered with Microsoft to develop generative AI-powered solutions that combine Press Ganey's dataset of over 7.6 billion patient encounters with Microsoft's AI, cloud, and ambient listening tools. This collaboration enables predictive analytics for patient safety, real-time actionable insights for providers, and secure data sharing via Azure, demonstrating that cloud-based PX platforms are driving personalization, efficiency, and improved patient experience.

Hence, such strategic collaborations underscore the growing role of cloud-based, AI-enabled patient experience platforms in delivering personalized, efficient, and data-driven care across healthcare settings.

"By end user, the healthcare payers segment is expected to grow at the highest CAGR during the forecast period."

By end user, the healthcare payers segment is expected to register the highest CAGR during the forecast period. Payers are increasingly investing in patient experience (PX) platforms to improve member engagement, streamline claims and administrative processes, and enhance overall satisfaction with health plan services. The growing emphasis on value-based care and outcomes-driven reimbursement models is prompting payers to leverage AI, analytics, and patient feedback tools to monitor service quality, predict member needs, and reduce preventable gaps in care.

Digital channels, such as member portals, teletriage, and automated communication tools, are being adopted to provide personalized, real-time support, improve adherence to preventive care, and strengthen patient loyalty. Additionally, regulatory mandates for interoperability and patient access, such as the US Cures Act and Europe's EHDS, are accelerating payer adoption of patient experience technologies. As a result, payers are emerging as a key growth driver in the market, reflecting their strategic focus on member experience and outcomes.

"North America is expected to hold the largest market share."

North America represents the leading regional market, supported by a well-established healthcare IT infrastructure, high adoption of digital health technologies, and a strong presence of leading patient experience technology providers. Healthcare organizations across the region are increasingly investing in digital patient engagement, patient portals, virtual care, automated communication, feedback management, and AI-enabled experience analytics to improve patient satisfaction and operational efficiency. The growing emphasis on patient-centric care, value-based healthcare, interoperability, and consumer-oriented healthcare delivery is further supporting adoption. In addition, continued investments by healthcare providers and technology companies in AI-powered personalization and digital front-door capabilities are strengthening the regional ecosystem. These factors are expected to maintain North America's leading position in the patient experience technology market over the forecast period.

The breakdown of primary participants is as mentioned below:

  • By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation - Directors: 30%, Managers: 34%, and Others: 36%
  • By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 5%

Key Players

The key players operating in the patient experience technology market include Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 RCM Inc. (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), and Salesforce, Inc. (US). These companies have adopted strategies such as strategic partnerships, collaborations, product launches, platform enhancements, investments in foundation models and generative AI, mergers and acquisitions, and geographic expansion to strengthen their market presence in the patient experience technology market.

Research Coverage

The report analyzes the patient experience technology market. It estimates the market size and future growth potential of various market segments based on offerings, function, end user, and region. The report also analyzes factors such as drivers, restraints, opportunities, and challenges influencing market growth. It evaluates opportunities across the patient experience technology ecosystem and assesses the competitive landscape for key stakeholders. The report also analyzes micro markets by growth trends, prospects, and contributions to the overall patient experience technology market. It forecasts market revenue across major regions and provides a comprehensive competitive analysis of leading market participants, including their company profiles, product portfolios, recent developments, and key growth strategies.

Reasons to Buy the Report

This report will help established firms and new entrants/smaller firms gauge the pulse of the market, which can help them gain a greater market share. Firms purchasing the report could use one or more of the following strategies to strengthen their market position.

This report provides insights on:

  • Analysis of key drivers (rising demand for digital engagement platforms and personalized patient care, increasing adoption of telehealth, mobile health apps, and AI-powered analytics, government initiatives and funding to accelerate healthcare digital transformation, growing focus on improving patient satisfaction and long-term engagement through real-time feedback tools, and expansion of cloud-based engagement platforms), restraints (data privacy and cybersecurity concerns restricting adoption, high implementation and integration costs for healthcare providers, limited interoperability between patient engagement systems and existing EHRs), opportunities (expansion in emerging markets with growing healthcare infrastructure, adoption of AI-driven personalization and predictive analytics for patient care, rising partnerships with pharma and payers to accelerate digital health adoption, and growing VR/AR platforms for enhanced patient education and adherence), and challenges (ensuring accuracy and reliability of patient feedback data and rapid technological evolution requiring continuous updates and training) influencing the growth of the patient experience technology market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient experience technology market
  • Market Development: Comprehensive information on the lucrative emerging markets, by offerings, functions, end user, and region
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient experience technology market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient experience technology market such as Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 RCM Inc. (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), Salesforce, Inc. (US), Vital (US), NexHealth (US), Collectly, Inc. (US), Business Integrity Services (US), and Bamboo Health (US)
Show more
Product Code: HIT 8057

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 PATIENT EXPERIENCE TECHNOLOGY MARKET OVERVIEW
  • 3.2 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING & REGION
  • 3.3 PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising demand for digital engagement platforms and personalized patient care
      • 4.2.1.2 Increasing adoption of telehealth, mobile health apps, and AI-powered analytics
      • 4.2.1.3 Government initiatives and funding for healthcare digital transformation
      • 4.2.1.4 Growing focus on improving patient satisfaction and long-term engagement
      • 4.2.1.5 Expansion of cloud-based engagement platforms
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Data privacy and cybersecurity concerns
      • 4.2.2.2 High implementation and integration costs for healthcare providers
      • 4.2.2.3 Limited interoperability between patient engagement systems and existing electronic health record systems
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growth opportunities in emerging market
      • 4.2.3.2 Adoption of AI-driven personalization and predictive analytics for patient care
      • 4.2.3.3 Strategic partnerships among technology providers, pharma companies, and payers
      • 4.2.3.4 Rising adoption of virtual reality and augmented reality
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Need to ensure accuracy and reliability of feedback data
      • 4.2.4.2 Rapid technological evolution
  • 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.2 BARGAINING POWER OF SUPPLIERS
  • 5.3 BARGAINING POWER OF BUYERS
  • 5.4 THREAT OF NEW ENTRANTS
  • 5.5 THREAT OF SUBSTITUTES
  • 5.6 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 MACROECONOMIC INDICATORS
    • 5.7.1 INTRODUCTION
    • 5.7.2 GDP TRENDS AND FORECAST
    • 5.7.3 HEALTHCARE DIGITALIZATION AND PATIENT ENGAGEMENT ADOPTION TRENDS
  • 5.8 VALUE CHAIN ANALYSIS
    • 5.8.1 PRODUCT DESIGN & DEVELOPMENT
    • 5.8.2 SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION
    • 5.8.3 IMPLEMENTATION & CHANGE MANAGEMENT
    • 5.8.4 EXPERIENCE ANALYTICS & REPORTING INSIGHTS
    • 5.8.5 POST-SALES SUPPORT & CONTINUOUS IMPROVEMENT
  • 5.9 ECOSYSTEM ANALYSIS
  • 5.10 PRICING ANALYSIS
    • 5.10.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.11 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.13 INVESTMENT AND FUNDING SCENARIO
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 IMPACT OF 2025 US TARIFFS ON PATIENT EXPERIENCE TECHNOLOGY MARKET
    • 5.15.1 INTRODUCTION
    • 5.15.2 KEY TARIFF RATES
    • 5.15.3 IMPACT ON COUNTRY/REGION
      • 5.15.3.1 US
      • 5.15.3.2 Europe
      • 5.15.3.3 Asia Pacific
    • 5.15.4 IMPACT ON END USERS
      • 5.15.4.1 Healthcare providers
      • 5.15.4.2 Healthcare payers
      • 5.15.4.3 Pharma & biotech companies
      • 5.15.4.4 Others

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 VOICE-OF-THE-PATIENT (VOP) PLATFORMS
    • 6.1.2 TELEHEALTH AND VIRTUAL CARE PLATFORMS
    • 6.1.3 PATIENT PORTALS AND PERSONAL HEALTH RECORDS
    • 6.1.4 REMOTE PATIENT MONITORING (RPM)
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 INTEROPERABILITY/API AND FHIR INFRASTRUCTURE
    • 6.2.2 PATIENT IDENTITY MANAGEMENT AND AUTHENTICATION SYSTEMS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
    • 6.3.2 POPULATION HEALTH MANAGEMENT (PHM) PLATFORMS
    • 6.3.3 PATIENT ENGAGEMENT SOLUTIONS
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 PATENT PUBLICATION TRENDS
    • 6.5.2 JURISDICTION ANALYSIS
    • 6.5.3 MAJOR PATENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 AI-POWERED DIGITAL FRONT DOOR AND INTELLIGENT PATIENT NAVIGATION
    • 6.6.2 PREDICTIVE AND PROACTIVE PATIENT EXPERIENCE MANAGEMENT
    • 6.6.3 PERSONALIZED, OMNICHANNEL, AND CONNECTED PATIENT ENGAGEMENT

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY ANALYSIS
      • 7.1.1.1 Regulatory bodies, government agencies, and other organizations
    • 7.1.2 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 INTRODUCTION
  • 8.2 DECISION-MAKING PROCESS
  • 8.3 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.3.2 KEY BUYING CRITERIA
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
    • 8.4.1 UNMET NEEDS
    • 8.4.2 END-USER EXPECTATIONS
  • 8.5 MARKET PROFITABILITY

9 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION

  • 9.1 INTRODUCTION
  • 9.2 APPOINTMENT SCHEDULING
    • 9.2.1 ENABLING OPERATIONAL EFFICIENCY AND PATIENT ACCESS
  • 9.3 PATIENT REGISTRATION
    • 9.3.1 OPTIMIZING FRONT-END WORKFLOWS AND DATA ACCURACY
  • 9.4 VIRTUAL CARE
    • 9.4.1 EXPANDING REMOTE ACCESS AND CONTINUITY OF CARE
  • 9.5 PATIENT COMMUNICATION
    • 9.5.1 DRIVING PATIENT ACTIVATION AND CARE ADHERENCE
  • 9.6 BILLING
    • 9.6.1 PUSH FOR TRANSPARENT & AUTOMATED FINANCIAL WORKFLOWS
  • 9.7 FEEDBACK MANAGEMENT
    • 9.7.1 FACILITATING CONTINUOUS IMPROVEMENT IN PATIENT EXPERIENCE
  • 9.8 OTHER FUNCTIONS
    • 9.8.1 GROWING FOCUS ON HOLISTIC, PATIENT-CENTRIC CARE

10 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING

  • 10.1 INTRODUCTION
  • 10.2 SOFTWARE
    • 10.2.1 ON-PREMISE SOFTWARE
      • 10.2.1.1 Ensuring data control, compliance, and system integration
    • 10.2.2 CLOUD-BASED
      • 10.2.2.1 Lower upfront costs and seamless interoperability to aid growth
    • 10.2.3 HYBRID SOFTWARE
      • 10.2.3.1 Ability to ensure maximum compliance and control to boost market
  • 10.3 SERVICES
    • 10.3.1 MANAGED SERVICES
      • 10.3.1.1 Rising demand for operational efficiency and risk mitigation to encourage growth
    • 10.3.2 PROFESSIONAL SERVICES
      • 10.3.2.1 Need for continuous patient engagement to contribute to growth

11 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER

  • 11.1 INTRODUCTION
    • 11.1.1 HEALTHCARE PROVIDERS
      • 11.1.1.1 Growing patient expectations and digital-first strategies
    • 11.1.2 HOSPITALS & HEALTH SYSTEMS
      • 11.1.2.1 Enterprise-wide digital platforms to unify patient journeys and optimize value-based care
    • 11.1.3 OUTPATIENT & AMBULATORY CARE CENTERS
      • 11.1.3.1 Digital transformation elevates patient experience in ambulatory settings
    • 11.1.4 PHYSICIAN & GROUP PRACTICES
      • 11.1.4.1 AI, EHRs, and mobile apps transform care delivery in group practices
    • 11.1.5 LONG-TERM CARE & POST-ACUTE FACILITIES
      • 11.1.5.1 Enhancing care quality and patient experience in LTC and PAC Facilities
    • 11.1.6 OTHER HEALTHCARE PROVIDERS
      • 11.1.6.1 Improving patient engagement and care efficiency across specialty and ambulatory settings to drive segment
  • 11.2 HEALTHCARE PAYERS
    • 11.2.1 ADVANCING MEMBER-CENTRIC CARE TO BOOST GROWTH
  • 11.3 PHARMA & BIOTECH COMPANIES
    • 11.3.1 PHARMA & BIOTECH ADVANCING PATIENT EXPERIENCE THROUGH DIGITAL SOLUTIONS
  • 11.4 OTHER END USERS
    • 11.4.1 ENABLERS OF STANDARDS, COMPLIANCE, AND INNOVATION DRIVING PATIENT EXPERIENCE TECHNOLOGY ADOPTION

12 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 US to dominate global market for patient experience technology
    • 12.2.3 CANADA
      • 12.2.3.1 Advancing patient-centric digital health solutions
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 UK
      • 12.3.2.1 NHS-driven patient-centric innovation
    • 12.3.3 GERMANY
      • 12.3.3.1 Digital health leadership and patient engagement
    • 12.3.4 FRANCE
      • 12.3.4.1 Advancing patient-centric digital health
    • 12.3.5 ITALY
      • 12.3.5.1 Regional growth and telemedicine expansion
    • 12.3.6 SPAIN
      • 12.3.6.1 Patient-centric digital health and regional innovation
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 JAPAN
      • 12.4.2.1 Rapidly growing elderly population to propel market expansion
    • 12.4.3 CHINA
      • 12.4.3.1 Widespread super-app integration to accelerate adoption
    • 12.4.4 INDIA
      • 12.4.4.1 National digital health programs accelerating market growth in India
    • 12.4.5 SOUTH KOREA
      • 12.4.5.1 Regulatory liberalization and ICT integration fueling market growth
    • 12.4.6 AUSTRALIA
      • 12.4.6.1 Mature healthcare system and digital infrastructure driving adoption
    • 12.4.7 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Brazil to dominate patient experience technology market in Latin America
    • 12.5.3 MEXICO
      • 12.5.3.1 Mexico emerges as a hub for retail-integrated and multilingual patient experience platforms
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Rising healthcare investments to fuel uptake
      • 12.6.2.2 Saudi Arabia
        • 12.6.2.2.1 Vision 2030 and MoH digital-first strategy
      • 12.6.2.3 UAE
        • 12.6.2.3.1 Government-led digital transformation and private-sector innovation
      • 12.6.2.4 Rest of GCC
        • 12.6.2.4.1 Rising demand for telehealth & virtual care
    • 12.6.3 SOUTH AFRICA
    • 12.6.4 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
  • 13.3 REVENUE ANALYSIS, 2021-2025
  • 13.4 MARKET SHARE ANALYSIS, 2025
  • 13.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.6 BRAND/SOFTWARE COMPARISON
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 13.7.5.1 Company footprint
      • 13.7.5.2 Region footprint
      • 13.7.5.3 Offering footprint
      • 13.7.5.4 Function footprint
      • 13.7.5.5 End user footprint
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • 13.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025
      • 13.8.5.1 Detailed list of key startups/SMEs
      • 13.8.5.2 Competitive benchmarking of key startups/SMEs
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 SOLUTION/SERVICE LAUNCHES
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 PRESS GANEY
      • 14.1.1.1 Business overview
      • 14.1.1.2 Solutions offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Solution launches and enhancements
        • 14.1.1.3.2 Deals
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 NATIONAL RESEARCH CORPORATION
      • 14.1.2.1 Business overview
      • 14.1.2.2 Solutions offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Solution launches and enhancements
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 MEDALLIA INC.
      • 14.1.3.1 Business overview
      • 14.1.3.2 Solutions offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Solution launches and enhancements
        • 14.1.3.3.2 Deals
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Right to win
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 PHREESIA
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Solution launches and enhancements
        • 14.1.4.3.2 Deals
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Right to win
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses and competitive threats
    • 14.1.5 NICE
      • 14.1.5.1 Business overview
      • 14.1.5.2 Solutions offered
      • 14.1.5.3 MnM view
        • 14.1.5.3.1 Right to win
        • 14.1.5.3.2 Strategic choices
        • 14.1.5.3.3 Weaknesses and competitive threats
    • 14.1.6 R1
      • 14.1.6.1 Business overview
      • 14.1.6.2 Solutions offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Solution launches and enhancements
        • 14.1.6.3.2 Deals
    • 14.1.7 EPIC SYSTEMS CORPORATION
      • 14.1.7.1 Business overview
      • 14.1.7.2 Solutions offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Solution launches and enhancements
        • 14.1.7.3.2 Deals
    • 14.1.8 IQVIA
      • 14.1.8.1 Business overview
      • 14.1.8.2 Solutions offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Solution launches and enhancements
    • 14.1.9 QUALTRICS
      • 14.1.9.1 Business overview
      • 14.1.9.2 Solutions offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
        • 14.1.9.3.2 Expansions
        • 14.1.9.3.3 Other developments
    • 14.1.10 RELIAS LLC
      • 14.1.10.1 Business overview
      • 14.1.10.2 Solutions offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Deals
    • 14.1.11 GETWELLNETWORK, INC.
      • 14.1.11.1 Business overview
      • 14.1.11.2 Solutions offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Solution launches and enhancements
        • 14.1.11.3.2 Deals
    • 14.1.12 CIPHERHEALTH INC.
      • 14.1.12.1 Business overview
      • 14.1.12.2 Solutions offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Solution launches and enhancements
        • 14.1.12.3.2 Deals
    • 14.1.13 KYRUUS, INC.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Solutions offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Solution launches and enhancements
        • 14.1.13.3.2 Deals
    • 14.1.14 RELATIENT
      • 14.1.14.1 Business overview
      • 14.1.14.2 Solutions offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Solution launches and enhancements
    • 14.1.15 ALIDA
      • 14.1.15.1 Business overview
      • 14.1.15.2 Solutions offered
    • 14.1.16 TWILIO INC.
      • 14.1.16.1 Business overview
      • 14.1.16.2 Solutions offered
      • 14.1.16.3 Recent developments
        • 14.1.16.3.1 Solution launches and enhancements
        • 14.1.16.3.2 Deals
    • 14.1.17 AVAAMO
      • 14.1.17.1 Business overview
      • 14.1.17.2 Products offered
      • 14.1.17.3 Recent developments
        • 14.1.17.3.1 Solution launches and enhancements
    • 14.1.18 CERTIFY HEALTH
      • 14.1.18.1 Business overview
      • 14.1.18.2 Solutions offered
      • 14.1.18.3 Recent developments
        • 14.1.18.3.1 Other developments
    • 14.1.19 LUMA HEALTH INC.
      • 14.1.19.1 Business overview
      • 14.1.19.2 Solutions offered
      • 14.1.19.3 Recent developments
        • 14.1.19.3.1 Solution launches and enhancements
        • 14.1.19.3.2 Deals
    • 14.1.20 SOLUTIONREACH
      • 14.1.20.1 Business overview
      • 14.1.20.2 Solutions offered
      • 14.1.20.3 Recent developments
        • 14.1.20.3.1 Solution launches and enhancements
    • 14.1.21 SALESFORCE, INC.
      • 14.1.21.1 Business overview
      • 14.1.21.2 Solutions offered
      • 14.1.21.3 Recent developments
        • 14.1.21.3.1 Solution launches and enhancements
  • 14.2 OTHER PLAYERS
    • 14.2.1 VITAL
    • 14.2.2 NEXHEALTH
    • 14.2.3 COLLECTLY, INC.
    • 14.2.4 BUSINESS INTEGRITY SERVICES
    • 14.2.5 BAMBOO HEALTH

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH DATA
    • 15.1.1 SECONDARY DATA
      • 15.1.1.1 Key data from secondary sources
    • 15.1.2 PRIMARY DATA
      • 15.1.2.1 Key data from primary sources
      • 15.1.2.2 Breakdown of primary sources
  • 15.2 RESEARCH METHODOLOGY DESIGN
  • 15.3 MARKET SIZE ESTIMATION
  • 15.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 15.5 RESEARCH ASSUMPTIONS
    • 15.5.1 MARKET SIZING ASSUMPTIONS
    • 15.5.2 OVERALL STUDY ASSUMPTIONS
  • 15.6 RISK ASSESSMENT
  • 15.7 RESEARCH LIMITATIONS
    • 15.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 15.7.2 SCOPE-RELATED LIMITATIONS

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS
Show more
Product Code: HIT 8057

List of Tables

  • TABLE 1 USD EXCHANGE RATES
  • TABLE 2 PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 PATIENT EXPERIENCE TECHNOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 4 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE SOFTWARE, BY KEY PLAYER, 2022-2025 (USD)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY, BY REGION, 2022-2025 (USD)
  • TABLE 6 PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 7 CASE STUDY 1: IMPROVED PATIENT-CENTERED CARE WITH DIGIVALET PATIENT EXPERIENCE PLATFORM
  • TABLE 8 CASE STUDY 2: PAPERLESS ADMISSIONS VIA PWC + SALESFORCE DIGITAL PATIENT PORTAL
  • TABLE 9 CASE STUDY 3: TIMELY PATIENT COMMUNICATIONS WITH TWILIO MESSAGING
  • TABLE 10 CASE STUDY 4: DIGITAL WAYFINDING & WI-FI ENHANCEMENTS BY WORLDWIDE TECHNOLOGY
  • TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT EXPERIENCE TECHNOLOGY
  • TABLE 13 PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY PATENTS/PATENT APPLICATIONS
  • TABLE 14 REGULATORY SCENARIO IN NORTH AMERICA
  • TABLE 15 REGULATORY SCENARIO IN EUROPE
  • TABLE 16 REGULATORY SCENARIO IN ASIA PACIFIC
  • TABLE 17 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
  • TABLE 18 REGULATORY SCENARIO IN LATIN AMERICA
  • TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
  • TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 26 PATIENT EXPERIENCE TECHNOLOGY MARKET: UNMET NEEDS
  • TABLE 27 PATIENT EXPERIENCE TECHNOLOGY MARKET: END-USER EXPECTATIONS
  • TABLE 28 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 29 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR APPOINTMENT SCHEDULING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 30 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT REGISTRATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 31 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR VIRTUAL CARE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 32 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT COMMUNICATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 33 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR BILLING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 34 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR FEEDBACK MANAGEMENT, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 37 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT, 2024-2031 (USD MILLION)
  • TABLE 38 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR ON-PREMISE SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 40 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 41 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HYBRID SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY SERVICE, 2024-2031 (USD MILLION)
  • TABLE 43 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR MANAGED SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 47 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 48 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHYSICIAN & GROUP PRACTICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 PATIENT EXPERIENCE TECHNOLOGY FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 58 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 60 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 61 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 62 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 63 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 65 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 66 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 67 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 68 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 69 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 70 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 71 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 72 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 73 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 74 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 75 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 76 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 77 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 79 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 80 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 81 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 82 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 83 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 84 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 85 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 86 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 87 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 88 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 89 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 90 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 91 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 92 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 93 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 94 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 95 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 96 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 97 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 98 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 99 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 100 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 101 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 102 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 103 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 104 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 105 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 106 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 107 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 108 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 109 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 110 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 111 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 112 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 113 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 114 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 115 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 116 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 117 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 118 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 119 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 127 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 128 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 129 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 130 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 131 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 132 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 133 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 134 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 135 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 136 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 137 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 138 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 140 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 142 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 143 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 144 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 146 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 147 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 148 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 149 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 150 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 151 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 152 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 153 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 154 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 155 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 156 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 157 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 158 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 160 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 161 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 162 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 163 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 164 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 165 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 166 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 168 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 169 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 170 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 171 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 172 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 173 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 174 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 175 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 176 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 177 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 178 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 179 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 180 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 181 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 183 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 184 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 185 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 186 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 187 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 189 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 190 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 191 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 192 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 193 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 194 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 195 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 196 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 197 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 198 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 199 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 200 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 201 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 202 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 204 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 205 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 206 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 207 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 208 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 210 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 211 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 212 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 213 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 214 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 216 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 217 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 218 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 219 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 220 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 223 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 224 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 226 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 228 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 229 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 230 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, JANUARY 2023-JULY 2026
  • TABLE 232 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 233 PATIENT EXPERIENCE TECHNOLOGY MARKET: REGION FOOTPRINT
  • TABLE 234 PATIENT EXPERIENCE TECHNOLOGY MARKET: OFFERING FOOTPRINT
  • TABLE 235 PATIENT EXPERIENCE TECHNOLOGY MARKET: FUNCTION FOOTPRINT
  • TABLE 236 PATIENT EXPERIENCE TECHNOLOGY MARKET: END USER FOOTPRINT
  • TABLE 237 PATIENT EXPERIENCE TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 238 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 239 PATIENT EXPERIENCE TECHNOLOGY MARKET: SOLUTION/SERVICE LAUNCHES, JANUARY 2023-JULY 2026
  • TABLE 240 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEALS, JANUARY 2023 - JULY 2026
  • TABLE 241 PATIENT EXPERIENCE TECHNOLOGY MARKET: EXPANSIONS, JANUARY 2023 - JULY 2026
  • TABLE 242 PRESS GANEY: COMPANY OVERVIEW
  • TABLE 243 PRESS GANEY: SOLUTIONS OFFERED
  • TABLE 244 PRESS GANEY: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 245 PRESS GANEY: DEALS, JANUARY 2023-JULY 2026
  • TABLE 246 NATIONAL RESEARCH CORPORATION: COMPANY OVERVIEW
  • TABLE 247 NATIONAL RESEARCH CORPORATION: SOLUTIONS OFFERED
  • TABLE 248 NATIONAL RESEARCH CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 249 MEDALLIA INC.: COMPANY OVERVIEW
  • TABLE 250 MEDALLIA INC.: SOLUTIONS OFFERED
  • TABLE 251 MEDALLIA INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 252 MEDALLIA INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 253 PHREESIA: COMPANY OVERVIEW
  • TABLE 254 PHREESIA: SOLUTIONS OFFERED
  • TABLE 255 PHREESIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 256 PHREESIA: DEALS, JANUARY 2023-JULY 2026
  • TABLE 257 NICE: COMPANY OVERVIEW
  • TABLE 258 NICE: SOLUTIONS OFFERED
  • TABLE 259 R1: COMPANY OVERVIEW
  • TABLE 260 R1: SOLUTIONS OFFERED
  • TABLE 261 R1 RCM INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 262 R1: DEALS, JANUARY 2023-JULY 2026
  • TABLE 263 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 264 EPIC SYSTEMS CORPORATION: SOLUTIONS OFFERED
  • TABLE 265 EPIC SYSTEMS CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 266 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023-JULY 2026
  • TABLE 267 IQVIA: COMPANY OVERVIEW
  • TABLE 268 IQVIA: SOLUTIONS OFFERED
  • TABLE 269 IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 270 QUALTRICS: COMPANY OVERVIEW
  • TABLE 271 QUALTRICS: SOLUTIONS OFFERED
  • TABLE 272 QUALTRICS: DEALS, JANUARY 2023-JULY 2026
  • TABLE 273 QUALTRICS: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 274 QUALTRICS: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 275 RELIAS LLC: COMPANY OVERVIEW
  • TABLE 276 RELIAS LLC: SOLUTIONS OFFERED
  • TABLE 277 RELIAS LLC: DEALS, JANUARY 2023-JULY 2026
  • TABLE 278 GETWELLNETWORK, INC.: COMPANY OVERVIEW
  • TABLE 279 GETWELLNETWORK, INC.: SOLUTIONS OFFERED
  • TABLE 280 GETWELLNETWORK, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 281 GETWELLNETWORK, INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 282 CIPHERHEALTH INC.: COMPANY OVERVIEW
  • TABLE 283 CIPHERHEALTH INC.: SOLUTIONS OFFERED
  • TABLE 284 CIPHERHEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 285 CIPHERHEALTH INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 286 KYRUUS, INC.: COMPANY OVERVIEW
  • TABLE 287 KYRUUS, INC.: SOLUTIONS OFFERED
  • TABLE 288 KYRUUS, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 289 KYRUUS, INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 290 RELATIENT: COMPANY OVERVIEW
  • TABLE 291 RELATIENT: SOLUTIONS OFFERED
  • TABLE 292 RELATIENT: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 293 ALIDA: COMPANY OVERVIEW
  • TABLE 294 ALIDA: SOLUTIONS OFFERED
  • TABLE 295 TWILIO INC.: COMPANY OVERVIEW
  • TABLE 296 TWILIO INC.: SOLUTIONS OFFERED
  • TABLE 297 TWILIO INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 298 TWILIO INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 299 AVAAMO: COMPANY OVERVIEW
  • TABLE 300 AVAAMO: SOLUTIONS OFFERED
  • TABLE 301 AVAAMO: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 302 CERTIFY HEALTH: COMPANY OVERVIEW
  • TABLE 303 CERTIFY HEALTH: SOLUTIONS OFFERED
  • TABLE 304 CERTIFY HEALTH: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 305 LUMA HEALTH INC.: COMPANY OVERVIEW
  • TABLE 306 LUMA HEALTH INC.: SOLUTIONS OFFERED
  • TABLE 307 LUMA HEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 308 LUMA HEALTH INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 309 SOLUTIONREACH: COMPANY OVERVIEW
  • TABLE 310 SOLUTIONREACH: SOLUTIONS OFFERED
  • TABLE 311 SOLUTIONREACH: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 312 SALESFORCE, INC.: COMPANY OVERVIEW
  • TABLE 313 SALESFORCE, INC.: SOLUTIONS OFFERED
  • TABLE 314 SALESFORCE, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023-JULY 2026
  • TABLE 315 VITAL: COMPANY OVERVIEW
  • TABLE 316 NEXHEALTH: COMPANY OVERVIEW
  • TABLE 317 COLLECTLY, INC.: COMPANY OVERVIEW
  • TABLE 318 BUSINESS INTEGRITY SERVICES: COMPANY OVERVIEW
  • TABLE 319 BAMBOO HEALTH: COMPANY OVERVIEW
  • TABLE 320 FACTOR ANALYSIS
  • TABLE 321 RISK ASSESSMENT: PATIENT EXPERIENCE TECHNOLOGY MARKET

List of Figures

  • FIGURE 1 PATIENT EXPERIENCE TECHNOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL PATIENT EXPERIENCE TECHNOLOGY MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2023-2026
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF PATIENT EXPERIENCE TECHNOLOGY MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PATIENT EXPERIENCE TECHNOLOGY MARKET DURING FORECAST PERIOD
  • FIGURE 8 INCREASING ADOPTION OF DIGITAL HEALTH SOLUTIONS TO ENHANCE PATIENT ENGAGEMENT
  • FIGURE 9 SOFTWARE/PLATFORMS IN NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 11 PATIENT EXPERIENCE TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 13 PATIENT EXPERIENCE TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 14 PATIENT EXPERIENCE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 15 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY, BY REGION, 2022-2025 (USD)
  • FIGURE 16 PATIENT EXPERIENCE TECHNOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 17 RECENT FUNDING ACTIVITY IN PATIENT EXPERIENCE TECHNOLOGY MARKET
  • FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN PATIENT EXPERIENCE TECHNOLOGY, 2015-2026
  • FIGURE 19 JURISDICTION ANALYSIS OF PATIENT EXPERIENCE TECHNOLOGY PATENTS, JANUARY 2015-SEPTEMBER 2026
  • FIGURE 20 PATIENT EXPERIENCE TECHNOLOGY MARKET: PATENT ANALYSIS, JANUARY 2015-SEPTEMBER 2026
  • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 23 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 24 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 25 PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2021-2025 (USD MILLION)
  • FIGURE 26 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2025
  • FIGURE 27 EV/EBITDA OF KEY VENDORS
  • FIGURE 28 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 29 PATIENT EXPERIENCE TECHNOLOGY MARKET: BRAND/SOFTWARE COMPARISON
  • FIGURE 30 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 31 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 32 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 33 NATIONAL RESEARCH CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 34 PHREESIA: COMPANY SNAPSHOT (2025)
  • FIGURE 35 NICE: COMPANY SNAPSHOT (2025)
  • FIGURE 36 IQVIA: COMPANY SNAPSHOT (2025)
  • FIGURE 37 TWILIO INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 38 SALESFORCE, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 39 RESEARCH DESIGN
  • FIGURE 40 PRIMARY SOURCES
  • FIGURE 41 INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 42 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 43 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 44 SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 45 PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ESTIMATION APPROACH
  • FIGURE 46 BOTTOM-UP APPROACH
  • FIGURE 47 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026-2031)
  • FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 49 TOP-DOWN APPROACH
  • FIGURE 50 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!